Neuer Vorstand fr Heidelberg Pharma - goingpublic.de
| HPHA Stock | EUR 2.42 0.01 0.41% |
About 54% of Heidelberg Pharma's investor base is interested to short. The analysis of current outlook of investing in Heidelberg Pharma AG suggests that many traders are impartial regarding Heidelberg Pharma's prospects. Heidelberg Pharma's investing sentiment overview a quick insight into current market opportunities from investing in Heidelberg Pharma AG. Many technical investors use Heidelberg Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Heidelberg Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Heidelberg daily returns and investor perception about the current price of Heidelberg Pharma AG as well as its diversification or hedging effects on your existing portfolios.
Heidelberg |
Neuer Vorstand fr Heidelberg Pharma goingpublic.de
Read at news.google.com
 |
Heidelberg Pharma Fundamental Analysis
We analyze Heidelberg Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heidelberg Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heidelberg Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Heidelberg Pharma is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Heidelberg Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Heidelberg Pharma stock to make a market-neutral strategy. Peer analysis of Heidelberg Pharma could also be used in its relative valuation, which is a method of valuing Heidelberg Pharma by comparing valuation metrics with similar companies.
Peers
Heidelberg Pharma Related Equities
| M1L | Maple Leaf | 0.71 | ||||
| XSFA | SENECA FOODS | 0.73 | ||||
| SD5 | STEEL DYNAMICS | 0.85 | ||||
| EDJ | CALTAGIRONE EDITORE | 1.36 | ||||
| NPS | Nippon Steel | 1.51 | ||||
| TIA | Tianjin Capital | 2.56 |
Other Information on Investing in Heidelberg Stock
Heidelberg Pharma financial ratios help investors to determine whether Heidelberg Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Heidelberg with respect to the benefits of owning Heidelberg Pharma security.